Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

A+ or A-, B+ or B-, AB+ or AB-, and O+ or O-. The first step is called “forward typing.” Your blood cells are mixed with antibodies against type A and B blood, and the sample is checked to see ...

In a new investigation, scientists from La Jolla Institute for Immunology (LJI) have shown how antibodies, collected from this clinical study volunteer, bind to the SARS-CoV-2 "Spike" protein to ...

Reports of reinfection instead may be cases of drawn-out illness. A decline in antibodies is normal after a few weeks, and people are protected from the coronavirus in other ways. By Apoorva ...

More than three years into the pandemic, an overwhelming majority of Americans have some level of COVID-19 antibodies circulating in their bodies, the U.S. Centers for Disease Control and ...

The figures are based on the final batch of results from the agency's nationwide studies of antibodies in Americans ages 16 and up. Federal officials often cited estimates from these studies in ...